LongMoE: New Framework for Multimodal Clinical Learning with Missing Data and Patient Trajectories
Researchers introduced LongMoE, a machine learning framework designed to handle multimodal clinical data (imaging, text, health records) when some data types are missing and patient conditions change over time. The framework combines imputation, temporal pattern recognition, and expert routing to address two key challenges that existing methods handle separately. This approach could improve diagnostic accuracy in real-world clinical settings where complete data is rarely available.
LongMoE is a unified framework that addresses two persistent challenges in multimodal clinical machine learning: modality missingness (when some data types are unavailable at patient visits) and longitudinal dynamics (when the significance of observations depends on a patient's evolving disease trajectory). The framework integrates context-aware imputation, attentional tokenization to capture temporal patterns across irregular visit sequences, a trajectory-aware encoder to model disease progression, and context-conditioned Sparse Mixture-of-Experts routing for patient-specific expert selection. The researchers evaluated LongMoE on three major clinical datasets: ADNI (Alzheimer's Disease Neuroimaging Initiative), OASIS-3 (Open Access Series of Imaging Studies), and MIMIC-IV (Medical Information Mart for Intensive Care). Results demonstrated that LongMoE improves robustness when modalities are missing or weak while remaining competitive when all data types are available, establishing a foundation for longitudinally-aware multimodal clinical learning.
What's missing
The paper does not provide quantitative performance metrics (accuracy, AUC, F1 scores) in the abstract; specific improvements over baseline methods are not stated. Clinical validation timelines and potential deployment considerations are not discussed. The study's limitations regarding dataset characteristics, generalizability to other clinical domains, and computational requirements are not addressed in the abstract.
What different sources said
- arXiv cs.LGCenter
LongMoE: Longitudinal Multimodal Learning via Trajectory-Aware Mixture-of-Experts
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.